Nothing Special   »   [go: up one dir, main page]
This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 5
2004 3
2005 1
2006 2
2007 2
2008 2
2010 3
2012 1
2014 1
2015 6
2016 2
2017 4
2018 6
2019 1
2020 2
2021 1
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for marc iglarz
Search for Marc Pillarz instead (2 results)
Role of endothelin-1 in hypertension.
Iglarz M, Schiffrin EL. Iglarz M, et al. Curr Hypertens Rep. 2003 Apr;5(2):144-8. doi: 10.1007/s11906-003-0071-4. Curr Hypertens Rep. 2003. PMID: 12642014 Review.
Granulomatous lung inflammation is nanoparticle type-dependent.
Pacheco Y, Ponchon M, Lebecque S, Calender A, Bernaudin JF, Valeyre D, Iglarz M, Strasser DS, Studer R, Freti D, Renno T, Bentaher A. Pacheco Y, et al. Among authors: iglarz m. Exp Lung Res. 2018 Feb;44(1):25-39. doi: 10.1080/01902148.2017.1412541. Epub 2018 Jan 11. Exp Lung Res. 2018. PMID: 29324063 Free article.
Mechanisms of ET-1-induced endothelial dysfunction.
Iglarz M, Clozel M. Iglarz M, et al. J Cardiovasc Pharmacol. 2007 Dec;50(6):621-8. doi: 10.1097/FJC.0b013e31813c6cc3. J Cardiovasc Pharmacol. 2007. PMID: 18091577 Review.
Genetic determinants of vascular reactivity.
Henrion D, Benessiano J, Iglarz M, Philip I, Levy BI. Henrion D, et al. Among authors: iglarz m. Curr Hypertens Rep. 2002 Feb;4(1):41-8. doi: 10.1007/s11906-002-0052-z. Curr Hypertens Rep. 2002. PMID: 11790291 Review.
Endothelin-2 in ovarian follicle rupture.
Ko C, Gieske MC, Al-Alem L, Hahn Y, Su W, Gong MC, Iglarz M, Koo Y. Ko C, et al. Among authors: iglarz m. Endocrinology. 2006 Apr;147(4):1770-9. doi: 10.1210/en.2005-1228. Epub 2006 Jan 12. Endocrinology. 2006. PMID: 16410304
Identification of a novel role for endothelins within the oviduct.
Jeoung M, Lee S, Hawng HK, Cheon YP, Jeong YK, Gye MC, Iglarz M, Ko C, Bridges PJ. Jeoung M, et al. Among authors: iglarz m. Endocrinology. 2010 Jun;151(6):2858-67. doi: 10.1210/en.2009-1155. Epub 2010 Mar 31. Endocrinology. 2010. PMID: 20357223 Free PMC article.
Effects of the Dual Endothelin Receptor Antagonist Aprocitentan on Body Weight and Fluid Homeostasis in Healthy Subjects on a High Sodium Diet.
Gueneau de Mussy P, Sidharta PN, Wuerzner G, Maillard MP, Guérard N, Iglarz M, Flamion B, Dingemanse J, Burnier M. Gueneau de Mussy P, et al. Among authors: iglarz m. Clin Pharmacol Ther. 2021 Mar;109(3):746-753. doi: 10.1002/cpt.2043. Epub 2020 Sep 29. Clin Pharmacol Ther. 2021. PMID: 32897570 Free PMC article. Clinical Trial.
44 results